Vliyanie kratkosrochnoy terapii rozuvastatinom na pokazateli lipidnogo obmena u bol'nykh ishemicheskoy bolezn'yu serdtsa


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The evaluation of the influence of therapy with Mertenil (rosuvastatin), produced by the «Gedeon Richter» company, on lipid profile and blood biochemical parameters in 50 patients with coronary artery disease in a traditional medical practice was performed. It was shown that the use of rosuvastatin at initial dose of 10 mg/day for a month has allowed to achieve the target low density lipoprotein (LDL) cholesterol levels in 42% of patients. As a result of this treatment, the LDL cholesterol and triglycerides levels have decreased by 27 and 37%, respectively, and the high-density lipoprotein cholesterol levels have increased by 9%. Mertenil (rosuvastatin) was well tolerated and did not cause side effects.

Full Text

Restricted Access

References

  1. Шальнова С.А., Деев А.Д. Тенденция смертности в России в начале XXI века (по данным официальной статистики). Кардиоваскулярная терапия и профилактика. 2011; 10(6).
  2. Марцевич С.Ю., Кутишенко Н.П. Достижение целевого уровня липидов у больных высокого сердечно-сосудистого риска: имеет ли значение выбор препарата? Рациональная фармакотерапия в кардиологии. 2008; 1.
  3. Shepherd J., Hunninghake D.B., Stein E.A., et al. Safety of rosuvastatin. Am. J. Cardiol. 2004; 94: 882-88.
  4. LaRosa J.C. Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am. J. Cardiol. 2007; 100: 240-42.
  5. Schwartz G.G., Bolognese M.A., Tremblay B.P., et al. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. Am. Heart J. 2004; 148(1): е4.
  6. Schuster H., Barter P.J., Stender S., et al. Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURYI) study. Am. Heart J. 2004; 147: 705-13.
  7. Insull W. Jr, Ghali J.K., Hassman D.R., et al. SOLAR Study Group Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial. Mayo Clin. Proc. 2007; 82: 543-50.
  8. Rubba P., Marotta G., Gentile M. Efficacy and safety of rosuvastatin in the management of dyslipidemia. Vasc. Health Risk Manag. 2009; 5: 343-52.
  9. McKenney J.M. Efficacy and safety of rosuvastatin in treatment of dyslipidemia. Am. J. Health Syst. Pharm. 2005; 62: 1033-47.
  10. Jones P.H., Davidson M.H., Stain E.A., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin and pravastatin across doses (STELLAR Trial). Am. J. Cardiol. 2003; 92 (2): 152-60.
  11. Jones P.H., Hunninghake D.B., Ferdinand K.C., et al. Effect of rosuvastatin versus atorvastatin, simvastatin and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins and lipid rations in patients with hypercholesterolemia: additional results from the STELLAR trial. Clin. Ther. 2004; 26(9): 1388-99.
  12. Fonseca F.A., Ruiz A., Cardona-Munoz E.G., et al. The DISCOVERY PENTA study: a Direct Statin Comparison of LDL-C Value - and Evaluation of rosuvastatin therapy compared with ator-vaststin. Curr. Med. Res. Opin. 2005; 21(8): 1307-15.
  13. Stender S., Schuster H., Barter P., et al. MERCURY Study Group. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes, Obes. Metab. 2005; 7(4): 430-38.
  14. Происторм А.М., Скороходкина С.В., Крейтер М.Л., Гуменюк А.Г. Сравнительная эффективность и безопасность Мертенила (розувастатина) у пациентов с гиперлипидемией. Медицинские новости. 2013; 3: 51-6.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies